Aarash Bordbar

Company: Sinopia Biosciences

Job title: Co-Founder, Chief Technology Officer

Seminars:

Multi-Omics Discovery & In Vivo Validation of Novel Targets for Neurology & Oncology 3:15 pm

Applying a data-driven approach to drug discovery by integrating large-scale multi-omics datasets with advanced AI/ML tools to uncover biology and discover novel therapeutic targets Discovery and development of SB-0110, a first-in-class small molecule for Parkinson’s disease and levodopa-induced dyskinesia Generating and deploying metabolomics-based models for drug discovery, demonstrating superior performance to transcriptomics in initial applicationsRead more

day: Conference Day Two